Literature DB >> 18234874

Rapid detection of triazole antifungal resistance in Aspergillus fumigatus.

Guillermo Garcia-Effron1, Amanda Dilger, Laura Alcazar-Fuoli, Steven Park, Emilia Mellado, David S Perlin.   

Abstract

Triazole resistance in Aspergillus fumigatus is an uncommon but rising phenomenon. Susceptibility testing is rarely performed and can take 48 h or longer, which is an impediment to effective therapy. Molecular diagnostic probing of well-defined resistance mechanisms, which serve as surrogate markers, provides an alternative approach to rapidly (within hours) and efficiently identify resistant strains. The mechanisms of triazole resistance in A. fumigatus are limited to amino acid substitutions in the drug target Cyp51A and include amino acid substitutions at the positions Gly 54, Gly 138, Met 220, and Leu 98, coupled with a tandem repetition in the gene promoter. We report the development of a real-time PCR assay utilizing molecular beacons to assess triazole resistance markers in A. fumigatus. When combined in a multiplex platform, the assay provides a comprehensive evaluation of drug resistance in A. fumigatus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18234874      PMCID: PMC2292958          DOI: 10.1128/JCM.02330-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  42 in total

1.  Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients.

Authors:  Kieren A Marr; Rachel A Carter; Fulvio Crippa; Anna Wald; Lawrence Corey
Journal:  Clin Infect Dis       Date:  2002-02-26       Impact factor: 9.079

Review 2.  Recent trends in the epidemiology of invasive mycoses.

Authors:  Thomas A Clark; Rana A Hajjeh
Journal:  Curr Opin Infect Dis       Date:  2002-12       Impact factor: 4.915

3.  Azole cross-resistance in Aspergillus fumigatus.

Authors:  J Mosquera; D W Denning
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

4.  Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole.

Authors:  Adriana M Nascimento; Gustavo H Goldman; Steven Park; Salvatore A E Marras; Guillaume Delmas; Uma Oza; Karen Lolans; Michael N Dudley; Paul A Mann; David S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

5.  A point mutation in the 14alpha-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus.

Authors:  T M Diaz-Guerra; E Mellado; M Cuenca-Estrella; J L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

6.  Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

Authors:  Raoul Herbrecht; David W Denning; Thomas F Patterson; John E Bennett; Reginald E Greene; Jörg-W Oestmann; Winfried V Kern; Kieren A Marr; Patricia Ribaud; Olivier Lortholary; Richard Sylvester; Robert H Rubin; John R Wingard; Paul Stark; Christine Durand; Denis Caillot; Eckhard Thiel; Pranatharthi H Chandrasekar; Michael R Hodges; Haran T Schlamm; Peter F Troke; Ben de Pauw
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

7.  Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate.

Authors:  John W Slaven; Michael J Anderson; Dominique Sanglard; Graham K Dixon; Jacques Bille; Ian S Roberts; David W Denning
Journal:  Fungal Genet Biol       Date:  2002-08       Impact factor: 3.495

8.  Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14alpha-demethylase.

Authors:  Paul A Mann; Raulo M Parmegiani; Shui-Qing Wei; Cara A Mendrick; Xin Li; David Loebenberg; Beth DiDomenico; Roberta S Hare; Scott S Walker; Paul M McNicholas
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

9.  Voriconazole in the treatment of invasive mold infections in transplant recipients.

Authors:  J Fortún; P Martín-Dávila; M A Sánchez; V Pintado; M E Alvarez; A Sánchez-Sousa; S Moreno
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-06-24       Impact factor: 3.267

10.  Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi.

Authors:  D J Diekema; S A Messer; R J Hollis; R N Jones; M A Pfaller
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

View more
  32 in total

Review 1.  Xenobiotic efflux in bacteria and fungi: a genomics update.

Authors:  Ravi D Barabote; Jose Thekkiniath; Richard E Strauss; Govindsamy Vediyappan; Joe A Fralick; Michael J San Francisco
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  2011

2.  Use of a high-resolution melt assay to characterize codon 54 of the cyp51A gene of Aspergillus fumigatus on a Rotor-Gene 6000 instrument.

Authors:  M J Tuohy; V Reja; S Park; D S Perlin; M Wnek; G W Procop; B Yen-Lieberman
Journal:  Antimicrob Agents Chemother       Date:  2010-03-01       Impact factor: 5.191

3.  Assessment of two new molecular methods for identification of Candida parapsilosis sensu lato species.

Authors:  Guillermo Garcia-Effron; Emilia Canton; Javier Pemán; Amanda Dilger; Eva Romá; David S Perlin
Journal:  J Clin Microbiol       Date:  2011-07-27       Impact factor: 5.948

Review 4.  Molecular Diagnostic Testing for Aspergillus.

Authors:  Margaret V Powers-Fletcher; Kimberly E Hanson
Journal:  J Clin Microbiol       Date:  2016-08-03       Impact factor: 5.948

5.  A Simple Method To Detect Point Mutations in Aspergillus fumigatus cyp51A Gene Using a Surveyor Nuclease Assay.

Authors:  Teppei Arai; Hidetaka Majima; Akira Watanabe; Katsuhiko Kamei
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

Review 6.  Aspergillus fumigatus and aspergillosis: From basics to clinics.

Authors:  A Arastehfar; A Carvalho; J Houbraken; L Lombardi; R Garcia-Rubio; J D Jenks; O Rivero-Menendez; R Aljohani; I D Jacobsen; J Berman; N Osherov; M T Hedayati; M Ilkit; D James-Armstrong; T Gabaldón; J Meletiadis; M Kostrzewa; W Pan; C Lass-Flörl; D S Perlin; M Hoenigl
Journal:  Stud Mycol       Date:  2021-05-10       Impact factor: 16.097

Review 7.  Molecular Tools for the Detection and Deduction of Azole Antifungal Drug Resistance Phenotypes in Aspergillus Species.

Authors:  Anna Dudakova; Birgit Spiess; Marut Tangwattanachuleeporn; Christoph Sasse; Dieter Buchheidt; Michael Weig; Uwe Groß; Oliver Bader
Journal:  Clin Microbiol Rev       Date:  2017-10       Impact factor: 26.132

8.  Clinical itraconazole-resistant strains of Aspergillus fumigatus, isolated serially from a lung aspergilloma patient with pulmonary tuberculosis, can be detected with real-time PCR method.

Authors:  Hui Xu; Wei Chen; Lijuan Li; Zhe Wan; Ruoyu Li; Wei Liu
Journal:  Mycopathologia       Date:  2009-11-04       Impact factor: 2.574

9.  Comparison of assessment of oxygen consumption, Etest, and CLSI M38-A2 broth microdilution methods for evaluation of the susceptibility of Aspergillus fumigatus to posaconazole.

Authors:  Ricardo Araujo; Ana Espinel-Ingroff
Journal:  Antimicrob Agents Chemother       Date:  2009-08-24       Impact factor: 5.191

10.  Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing.

Authors:  Huiping Wang; Fanrong Kong; Tania C Sorrell; Bin Wang; Paul McNicholas; Namfon Pantarat; David Ellis; Meng Xiao; Fred Widmer; Sharon Ca Chen
Journal:  BMC Microbiol       Date:  2009-08-14       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.